Advent Life Sciences
Showcasing the significance of two new funds
Amphista Therapeutics
Announcing the company’s Series A financing, leading to raised awareness with potential partners, investors and employees.
Amphista Therapeutics: Series B Financing
Announcing the company's Series B financing, which will be used to accelerate the growing pipeline of potent and selective bifunctional molecules and to extend its proprietary TPD platform.
AstraZeneca
Positioning the Company as a Partner of Choice as well as facilitating an Internal Change Management Programme.
BC Platforms
Positioning the company as a thought leader in precision medicine raising awareness with customers and investors.
IRBM
Positioning the Company as a leading CDMO and highlighting their group Advent.
Medicxi
To launch Index’s new spin-out life sciences fund and publicise its first closing.
Pneumagen
Raising visibility of its technology platform for the treatment for COVID-19 and supporting a new website and fundraising announcement.
Vaccitech
Support with corporate and investor materials and media relations supporting the partnership of its ChAdOx platform with AstraZeneca for a COVID-19 vaccine.
Vaccitech IPO
Coordinated a communications plan with key stakeholders to maximise visibility of Vaccitech's Series B financing and NASDAQ IPO listing
Advent Life Sciences
Showcasing the significance of two new funds
Amphista Therapeutics
Announcing the company’s Series A financing, leading to raised awareness with potential partners, investors and employees.
Amphista Therapeutics: Series B Financing
Announcing the company's Series B financing, which will be used to accelerate the growing pipeline of potent and selective bifunctional molecules and to extend its proprietary TPD platform.
AstraZeneca
Positioning the Company as a Partner of Choice as well as facilitating an Internal Change Management Programme.
BC Platforms
Positioning the company as a thought leader in precision medicine raising awareness with customers and investors.
IRBM
Positioning the Company as a leading CDMO and highlighting their group Advent.
Medicxi
To launch Index’s new spin-out life sciences fund and publicise its first closing.
Pneumagen
Raising visibility of its technology platform for the treatment for COVID-19 and supporting a new website and fundraising announcement.
Vaccitech
Support with corporate and investor materials and media relations supporting the partnership of its ChAdOx platform with AstraZeneca for a COVID-19 vaccine.
Vaccitech IPO
Coordinated a communications plan with key stakeholders to maximise visibility of Vaccitech's Series B financing and NASDAQ IPO listing
